Panbela Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Panbela Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Panbela Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.17M, a 8.42% increase year-over-year.
  • Panbela Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$27.9M, a 18.7% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$25.3M, a 27.7% increase from 2022.
  • Panbela Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$34.9M, a 245% decline from 2021.
  • Panbela Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$10.1M, a 113% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$27.9M -$7.17M +$659K +8.42% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$28.6M -$7.15M -$1.3M -22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$27.3M -$7.12M -$2.01M -39.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$25.3M -$6.47M -$1.74M -36.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$23.5M -$7.83M -$3.43M -77.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$20.1M -$5.85M +$16.3M +73.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$36.4M -$5.11M -$1.45M -39.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$34.9M -$4.74M -$1.2M -33.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$33.7M -$4.4M -$2.26M -106% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$31.5M -$22.1M -$19.9M -906% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$11.5M -$3.67M -$1.41M -62.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$10.1M -$3.54M -$2.66M -302% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$7.48M -$2.14M -$471K -28.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$7.01M -$2.2M -$1.78M -425% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$5.23M -$2.26M -$459K -25.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$4.77M -$880K +$94K +9.65% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$4.86M -$1.67M -$297K -21.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.57M -$419K +$1.85M +81.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$6.42M -$1.8M -$217K -13.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$6.2M -$974K -$234K -31.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$5.97M -$1.37M -$449K -48.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.52M -$2.27M +$216K +8.69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$5.73M -$1.58M +$172K +9.81% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$5.91M -$740K +$1.43M +65.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$7.33M -$925K +$294K +24.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.63M -$2.49M -$1.07M -75.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-13
Q1 2018 -$6.55M -$1.75M +$3.82M +68.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-13
Q4 2017 -$10.4M -$2.17M +$63K +2.82% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$10.4M -$1.22M -$140K -13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$10.3M -$1.41M -$436K -44.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$9.86M -$5.57M -$4.75M -576% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$5.11M -$2.23M -$1.5M -206% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$3.61M -$1.08M -$286K -36.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$3.32M -$978K +$237K +19.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$3.56M -$824K +$1.37M +62.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$4.93M -$728K +$1.49M +67.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$6.42M -$793K +$351K +30.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$6.77M -$1.22M -$1.16M -2020% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$5.61M -$2.19M -$2.08M -1882% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$3.53M -$2.22M -$2.16M -3849% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$1.37M -$1.14M -$1.09M -1865% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$282K -$57.3K -$8.52K -17.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$274K -$111K -$61.8K -127% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$212K -$56.2K -$172K -149% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$40.2K -$58.2K -$132K -179% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $91.6K -$48.8K -$141K -153% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $233K -$48.8K -$14.8K -43.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-14
Q4 2012 $247K $116K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $73.6K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $92.2K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$34K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.